Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders' Equity

v3.22.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balance at May. 11, 2020
Balance (in Shares) at May. 11, 2020        
Issuance of common stock for cash $ 14,600 14,600
Issuance of common stock for cash (in Shares) 7,300,000        
Issuance of common stock for cash $ 313 246,826 247,139
Issuance of common stock for cash (in Shares) 156,250        
Issuance of common stock for cash    
Issuance of common stock for advances $ 25 20,575 20,600
Issuance of common stock for advances (in Shares) 12,875        
Net loss (40,984) (40,984)
Balance at Dec. 31, 2020 $ 14,938 267,401 (40,984) 241,355
Balance (in Shares) at Dec. 31, 2020 7,469,125        
Stock-based compensation expense 471,250 471,250
Issuance of shares for cash $ 1,271 1,207,655 1,208,926
Issuance of shares for cash (in Shares) 635,594        
Issuance of shares for services $ 15 749,985 750,000
Issuance of shares for services (in Shares) 150,000        
Share adjustment (Note 5)
Share adjustment (Note 5) (in Shares) 153,652        
Issuance of public warrants (3,600,000) (3,600,000)
Issuance of representatives’ warrants (187,200) (187,200)
Sale of Units, net of underwriting discounts and offering costs $ 480 20,554,320 20,554,800
Sale of Units, net of underwriting discounts and offering costs (in Shares) 4,800,000        
Sale of common stock and warrants, net of fees and costs $ 868 27,164,584 27,165,452
Sale of common stock and warrants, net of fees and costs (in Shares) 8,680,000        
Exercise of warrants for cash $ 112 6,999,888 $ 7,000,000
Exercise of warrants for cash (in Shares) 1,120,000      
Foreign currency translation (10,561) $ (10,561)
Net loss (2,173,521) (2,173,521)
Balance at Dec. 31, 2021 $ 17,684 $ 53,627,883 $ (10,561) $ (2,214,505) $ 51,420,501
Balance (in Shares) at Dec. 31, 2021 23,008,371